Wellstar/TMI Announces Estimated Three-Year Revenue Projections
07 Gennaio 2009 - 10:22PM
Marketwired
Wellstar International, Inc. (OTCBB: WLSI), a provider of
specialized diagnostic software and equipment, announced today its
updated revenue projection guidance for fiscal years 2009 through
2011, based on the leasing of its thermal imaging system to
long-term care ("LTC") facilities. Wellstar International announced
two days ago that the revolutionary imaging system developed by the
Company's TMI subsidiary, which can be used for the early detection
of pressure ulcers, is now being marketed to the vast LTC market in
the U.S. via a special leasing program. This lease program makes
these systems now more affordable and essentially a "must-have" for
long-term care facilities seeking to curtail potential liabilities
and receive a higher rating from CMS under the agency's "pay for
performance" standards.
Wellstar/TMI estimates revenues for its fiscal year 2009 will be
in excess of $16 million, for 2010, they should be in excess of $69
million, and revenues are projected to be $133 million in 2011. The
Company also anticipates that it will be cash flow positive in
fiscal year 2009.
The Company's wholly-owned subsidiary, Trillennium Medical
Imaging ("TMI"), has begun marketing its thermal imaging system to
the approximately 16,000 LTC facilities throughout the United
States, and it anticipates installing devices as early as
April-2009. The Company has initiated a marketing plan that calls
for the installation of 300 FDA approved thermal imaging systems
per month through 2010, increasing that number to 400 per month by
2011.
Wellstar/TMI CEO, John Antonio, commented, "We believe that the
Company is in a strong position to capitalize on this technology
via the leasing program we have implemented. These revenues
projected are based on only one intended application of this
revolutionary thermal imaging system. We fully expect to market our
systems for other applications in the near future. I hope that
these revenue projections will now give investors a much clearer
picture of our emerging business."
ABOUT WELLSTAR INTERNATIONAL, INC.:
Wellstar International, Inc., through its wholly owned operating
subsidiary Trillennium Medical Imaging, Inc. (TMI), is poised to
become a leading diagnostic company in the health care industry.
TMI has developed and is marketing fully calibrated and functional,
thermal imaging systems that utilize state-of-the-art infrared
technologies and proprietary software to accurately and
cost-effectively measure physiological changes in the human body.
More information on the Company and its unique diagnostic software
and product line is available on Wellstar's corporate Website, by
visiting: www.wellstar.us.
FORWARD-LOOKING STATEMENTS:
This press release contains statements, which may constitute
'forward-looking statements' within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Prospective
investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those contemplated by such forward-looking statements. Important
factors currently known to management that could cause actual
results to differ materially from those in forward-statements
include fluctuation of operating results, the ability to compete
successfully and the ability to complete before-mentioned
transactions. The company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
CONTACT: Equiti-trend Advisors LLC (800) 953-3350 Toll-Free,
U.S. & Canada (858) 436-3350 Local or International 9:30 a.m.
to 5:00 p.m. Daily
Grafico Azioni Wellstar (CE) (USOTC:WLSI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Wellstar (CE) (USOTC:WLSI)
Storico
Da Giu 2023 a Giu 2024